Grant: Operating Grant
Université de Sherbrooke
$379,077.00
Optimal VAsopressor TItratiON (OVATION) Pilot Randomized controlled Trial
FY 2012-13
Summary
Patients who are admitted to intensive care units commonly suffer from illnesses that cause life-threatening low blood pressure. In this context, intensivists (physicians who care for patients in intensive care units) administer potent medications that increase blood pressure. Unfortunately, these medications cause adverse effects and it is not clear that they are better than the condition they are meant to treat. In this study, we intend to demonstrate the feasibility of a larger study that will investigate if administering medications to achieve higher blood pressures (that are near normal) is preferable to restricting the use of these medications by tolerating lower blood pressures. Patients will randomly receive blood pressure increasing medications for a higher or lower blood pressure target. In the definitive study, we will compare 90-day survival between groups but in this pilot study, we will validate that it is feasible to adhere to the protocol and achieve a different average blood pressure in each group while on study medication. This study is an important part of a research program that has the potential to change how we administer dangerous medications to the sickest of the sick in our hospitals - ultimately leading to safer, better patient care.
Department
Program
Operating Grant
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
267561
Name
Lamontagne Francois
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Clinical Investigation - D: Cardiovascular Systems
Projecttitle
Optimal VAsopressor TItratiON (OVATION) Pilot Randomized controlled Trial
Programtype2
Operating Grants
Orgnameinp2
Université de Sherbrooke
Cihramount2
$379,077
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Pilot Study; Randomized Controlled Trial; Shock; Titration; Vasopressors
Abstract
Patients who are admitted to intensive care units commonly suffer from illnesses that cause life-threatening low blood pressure. In this context, intensivists (physicians who care for patients in intensive care units) administer potent medications that increase blood pressure. Unfortunately, these medications cause adverse effects and it is not clear that they are better than the condition they are meant to treat. In this study, we intend to demonstrate the feasibility of a larger study that will investigate if administering medications to achieve higher blood pressures (that are near normal) is preferable to restricting the use of these medications by tolerating lower blood pressures. Patients will randomly receive blood pressure increasing medications for a higher or lower blood pressure target. In the definitive study, we will compare 90-day survival between groups but in this pilot study, we will validate that it is feasible to adhere to the protocol and achieve a different average blood pressure in each group while on study medication. This study is an important part of a research program that has the potential to change how we administer dangerous medications to the sickest of the sick in our hospitals - ultimately leading to safer, better patient care.
Competitiondate
201209
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Lamontagne, Francois; Hebert, Paul C
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $379,077~ $0~